CNBC Stock Blog
- Tobacco Stocks a Hot Dividend Play: Analyst
- Forget the Earnings, Disney’s Issue Is the Multiple: Analyst
- Drug Stocks Do Well in ‘Gloom and Doom’ Market: Analyst
- 6 Stocks Unworthy of Biotech Bull Market
- Three Phases of the Rally to Watch Out For: Strategist
- Morgan Stanley Bulls Look for More
- Top 4 Staffing Stocks for an Improving Economy
- Coke Is a ‘Recession-Proof’ Stock: Analyst
ABOUT THE CNBC STOCK BLOG
RSS FEED
CNBC EXPLAINS
Little-Known Israeli Gems For Investors
Text Size 
 |
Everyone knows about generic pharmaceutical giant Teva
[TEVA
Loading...
()
], but what other promising investments lie on the eastern shore of the Mediterranean?
Recommendations:
"I'll start with Cellcom
[CEL
Loading...
()
], which is the market leader in terms of cellular providers," Haim Israel told CNBC.
"Cellcom has roughly 34 percent market share, and has been operational since 1993."
The wireless business boasts other good investments.
"The same goes for Partner Communications
[PTNR
Loading...
()
], which is the second-largest cellular provider in Israel, with one third of the market, but also the market leader in terms of 3-G services," he said.
Haim Israel also recommends Israel Chemicals
[ICLTV
Loading...
()
], like the better-known Teva one of the world's largest pharmaceutical makers.
"[It's] definitely one of the key benefiters from all the agriculture-commodity boom that we've seen over the last year, fifth-largest fertilizer producer in the world, also the biggest producer of bromine compounds in the world," he said.
"It saw a massive increase in revenues, net income -- more than doubled its net income this year -- and we expect the trend to continue."
Disclosures:
Disclosure information for Haim Israel was not immediately available.
Data is a real-time snapshot *Data is delayed at least 15 minutes
